(EFX) Equifax - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2944291051

Credit Reports, Analytics, Identity Verification, Workforce Solutions, Debt Recovery

EFX EPS (Earnings per Share)

EPS (Earnings per Share) of EFX over the last years for every Quarter: "2020-09": 1.87, "2020-12": 2, "2021-03": 1.97, "2021-06": 1.98, "2021-09": 1.85, "2021-12": 1.84, "2022-03": 2.22, "2022-06": 2.09, "2022-09": 1.73, "2022-12": 1.52, "2023-03": 1.43, "2023-06": 1.71, "2023-09": 1.76, "2023-12": 1.81, "2024-03": 1.5, "2024-06": 1.82, "2024-09": 1.85, "2024-12": 2.12, "2025-03": 1.53, "2025-06": 2, "2025-09": 0,

EFX Revenue

Revenue of EFX over the last years for every Quarter: 2020-09: 1068.3, 2020-12: 1118.4, 2021-03: 1213, 2021-06: 1234.8, 2021-09: 1222.9, 2021-12: 1253.2, 2022-03: 1363.2, 2022-06: 1316.7, 2022-09: 1244.3, 2022-12: 1197.9, 2023-03: 1302, 2023-06: 1317.6, 2023-09: 1319.1, 2023-12: 1326.5, 2024-03: 1389.4, 2024-06: 1430.5, 2024-09: 1441.8, 2024-12: 1419.4, 2025-03: 1442, 2025-06: 1537, 2025-09: null,

Description: EFX Equifax October 14, 2025

Equifax Inc. (NYSE:EFX) is a data, analytics, and technology firm organized into three primary business segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The company’s core competency is aggregating and delivering credit-related and other public-record information to both commercial and consumer clients.

The Workforce Solutions segment supplies verification services-income, employment, education, criminal history, healthcare licensure, and sanctions-for U.S. individuals, while also offering employers automated payroll and human-resource management tools that span the full employment lifecycle.

The U.S. Information Solutions segment delivers a suite of consumer and commercial products, including credit reports, credit scoring, portfolio analytics, fraud detection, identity verification, mortgage services, financial marketing, and credit-monitoring solutions. This segment also provides consulting and identity-management services to financial institutions.

The International segment extends similar credit-information and analytics offerings to markets in the Americas, Europe, Asia-Pacific, and the Middle East, and adds debt-collection, recovery-management, and HR process-automation services for businesses and governments. Equifax operates in more than 20 countries, with a footprint that includes the United States, Canada, the United Kingdom, Brazil, India, and several Latin-American nations.

Recent performance metrics (2023) show total revenue of approximately $5.0 billion, a 5 % year-over-year increase driven largely by growth in the USIS segment (+7 % YoY) and modest expansion in International (+3 % YoY). The credit-reporting industry’s size is estimated at $30 billion globally, with a projected CAGR of 4 % through 2028, supported by rising consumer debt levels and tighter regulatory scrutiny on identity-theft mitigation. A key macro driver is the Federal Reserve’s interest-rate policy: higher rates tend to increase credit-file activity (new loans, credit inquiries) and thus boost demand for Equifax’s data services, but also raise default risk, which can shift client focus toward fraud-prevention tools.

For a deeper, data-driven assessment of Equifax’s valuation assumptions and scenario analyses, you might explore the analytical dashboards on ValueRay, where the platform’s granular driver-based models can help you quantify the impact of interest-rate shifts and regulatory changes on the company’s earnings outlook.

EFX Stock Overview

Market Cap in USD 27,990m
Sub-Industry Research & Consulting Services
IPO / Inception 1971-05-11

EFX Stock Ratings

Growth Rating 14.3%
Fundamental 60.6%
Dividend Rating 38.2%
Return 12m vs S&P 500 -28.5%
Analyst Rating 4.17 of 5

EFX Dividends

Dividend Yield 12m 0.78%
Yield on Cost 5y 1.32%
Annual Growth 5y 0.00%
Payout Consistency 92.1%
Payout Ratio 23.7%

EFX Growth Ratios

Growth Correlation 3m -33.4%
Growth Correlation 12m -33.2%
Growth Correlation 5y 48.1%
CAGR 5y 11.43%
CAGR/Max DD 3y (Calmar Ratio) 0.35
CAGR/Mean DD 3y (Pain Ratio) 0.99
Sharpe Ratio 12m 0.06
Alpha -45.78
Beta 1.675
Volatility 31.25%
Current Volume 1528.1k
Average Volume 20d 1148.2k
Stop Loss 220.6 (-3.7%)
Signal -1.03

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (639.7m TTM) > 0 and > 6% of Revenue (6% = 350.4m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 2.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -7.60% (prev -6.76%; Δ -0.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 1.39b > Net Income 639.7m (YES >=105%, WARN >=100%)
Net Debt (4.71b) to EBITDA (1.79b) ratio: 2.64 <= 3.0 (WARN <= 3.5)
Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (125.0m) change vs 12m ago 0.16% (target <= -2.0% for YES)
Gross Margin 55.80% (prev 55.62%; Δ 0.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 48.53% (prev 44.98%; Δ 3.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 4.97 (EBITDA TTM 1.79b / Interest Expense TTM 218.0m) >= 6 (WARN >= 3)

Altman Z'' 2.99

(A) -0.04 = (Total Current Assets 1.50b - Total Current Liabilities 1.95b) / Total Assets 11.92b
(B) 0.52 = Retained Earnings (Balance) 6.23b / Total Assets 11.92b
(C) 0.09 = EBIT TTM 1.08b / Avg Total Assets 12.04b
(D) 0.88 = Book Value of Equity 5.91b / Total Liabilities 6.68b
Total Rating: 2.99 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.59

1. Piotroski 6.0pt = 1.0
2. FCF Yield 2.80% = 1.40
3. FCF Margin 15.70% = 3.93
4. Debt/Equity 0.96 = 2.06
5. Debt/Ebitda 2.64 = -1.20
6. ROIC - WACC (= -2.53)% = -3.16
7. RoE 12.93% = 1.08
8. Rev. Trend 95.06% = 7.13
9. EPS Trend -33.00% = -1.65

What is the price of EFX shares?

As of October 28, 2025, the stock is trading at USD 229.02 with a total of 1,528,054 shares traded.
Over the past week, the price has changed by -0.91%, over one month by -10.40%, over three months by -4.75% and over the past year by -14.57%.

Is Equifax a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Equifax is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 60.59 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EFX is around 210.25 USD . This means that EFX is currently overvalued and has a potential downside of -8.2%.

Is EFX a buy, sell or hold?

Equifax has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy EFX.
  • Strong Buy: 11
  • Buy: 5
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the EFX price?

Issuer Target Up/Down from current
Wallstreet Target Price 276 20.5%
Analysts Target Price 276 20.5%
ValueRay Target Price 238.6 4.2%

EFX Fundamental Data Overview October 18, 2025

Market Cap USD = 27.99b (27.99b USD * 1.0 USD.USD)
P/E Trailing = 44.4618
P/E Forward = 25.7732
P/S = 4.7927
P/B = 5.6089
P/EG = 1.0516
Beta = 1.675
Revenue TTM = 5.84b USD
EBIT TTM = 1.08b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 847.0m USD (from shortTermDebt, last quarter)
Debt = 4.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.71b USD (from netDebt column, last quarter)
Enterprise Value = 32.70b USD (27.99b + Debt 4.90b - CCE 189.0m)
Interest Coverage Ratio = 4.97 (Ebit TTM 1.08b / Interest Expense TTM 218.0m)
FCF Yield = 2.80% (FCF TTM 917.0m / Enterprise Value 32.70b)
FCF Margin = 15.70% (FCF TTM 917.0m / Revenue TTM 5.84b)
Net Margin = 10.95% (Net Income TTM 639.7m / Revenue TTM 5.84b)
Gross Margin = 55.80% ((Revenue TTM 5.84b - Cost of Revenue TTM 2.58b) / Revenue TTM)
Gross Margin QoQ = 56.76% (prev 54.46%)
Tobins Q-Ratio = 2.74 (Enterprise Value 32.70b / Total Assets 11.92b)
Interest Expense / Debt = 1.08% (Interest Expense 53.1m / Debt 4.90b)
Taxrate = 26.29% (68.7m / 261.3m)
NOPAT = 799.1m (EBIT 1.08b * (1 - 26.29%))
Current Ratio = 0.77 (Total Current Assets 1.50b / Total Current Liabilities 1.95b)
Debt / Equity = 0.96 (Debt 4.90b / totalStockholderEquity, last quarter 5.10b)
Debt / EBITDA = 2.64 (Net Debt 4.71b / EBITDA 1.79b)
Debt / FCF = 5.14 (Net Debt 4.71b / FCF TTM 917.0m)
Total Stockholder Equity = 4.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.37% (Net Income 639.7m / Total Assets 11.92b)
RoE = 12.93% (Net Income TTM 639.7m / Total Stockholder Equity 4.95b)
RoCE = 12.05% (EBIT 1.08b / Capital Employed (Equity 4.95b + L.T.Debt 4.05b))
RoIC = 7.96% (NOPAT 799.1m / Invested Capital 10.03b)
WACC = 10.49% (E(27.99b)/V(32.89b) * Re(12.19%) + D(4.90b)/V(32.89b) * Rd(1.08%) * (1-Tc(0.26)))
Discount Rate = 12.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.24%
[DCF Debug] Terminal Value 69.14% ; FCFE base≈820.4m ; Y1≈1.01b ; Y5≈1.73b
Fair Price DCF = 127.8 (DCF Value 15.75b / Shares Outstanding 123.2m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -33.00 | EPS CAGR: -56.33% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.06 | Revenue CAGR: 7.98% | SUE: 1.98 | # QB: 2

Additional Sources for EFX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle